Clinical Trials Logo

Erythropoietin clinical trials

View clinical trials related to Erythropoietin.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01393418 Completed - Acute Kidney Injury Clinical Trials

Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery

EPO
Start date: November 2010
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate kidney biomarkers and determine if there is a correlation between Erythropoietin (EPO) levels and acute kidney injury after cardiac surgery. An early biomarker for kidney injury may be helpful in identifying, monitoring and managing patients at risk for kidney failure after cardiac surgery. To evaluate Erythropoietin's role as a predictor of poor renal function in the immediate post-bypass period we plan to compare EPO levels to Neutrophil gelatinase-associated lipocalin (NGAL).

NCT ID: NCT00526747 Completed - Anemia Clinical Trials

Erythropoietin Resistance in Anemia of Chronic Kidney Disease

Start date: August 2007
Phase: N/A
Study type: Observational

Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.